So Recce's technology seems to be gaining some attention, up 125% and counting in less than a week since listing. In this market that's a fantastic result no matter how you look at it.
Some big ups and downs to come...no doubt about that fact. Animal testing is all about proving efficacy and safety, which will mean finding toxicity levels amongst other things. Essentially there will be results along the way which may "sound" negative, but in fact are required findings (toxicity) and actually push the technology another step closer to commercialisation. Everything so far is looks to be exceeding plans in my view.
Very quick summary...
Synthetic antibiotic resistant to mutation/superbugs.
Testing indicates at least same effectiveness of leading treatments in treatment of superbugs.
Early testing indicates animals showed good/better health post treatment.
MOST IMPORANT - Testing shows superbugs are not resistant to treatment after a large number of cycles...unlike existing treatments.
RCE Price at posting:
43.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)